Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

出版年份 2014 全文链接

标题

作者

关键词

PARP Inhibition, Ewing Sarcoma, Unacceptable Adverse Event, Ewing Sarcoma Cell, Ewing Sarcoma Cell Line

出版物

Volume 14, Issue 1, Pages -

出版商

Springer Nature

发表日期

2014-11-06

DOI

10.1186/1471-2407-14-813

参考文献

查看 5 条相关文献

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now